Metabolic and health effects of isomeric fatty acids

Current Opinion in Lipidology

Volumn 16, Issue 1, 2005, Pages 27-30

  Mensink, Ronald P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Body composition; Conjugated linoleic acid; Glucose metabolism; Inflammation; Lipid metabolism; Trans fatty acids

Indexed keywords

CIS FATTY ACID; CONJUGATED LINOLEIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; TRANS FATTY ACID;

BODY COMPOSITION; BODY FAT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; EPIDEMIOLOGICAL DATA; GLUCOSE METABOLISM; HEALTH PROMOTION; HUMAN; IN VITRO STUDY; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID METABOLISM; LIPID PEROXIDATION; NONHUMAN; NUTRIENT CONTENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT;

ANIMALIA;

EID: 14744297613     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200502000-00006     Document Type: Review

References (30)

1. Katan MB, Mensink RP, Zock PL. Trans fatty acids and their effects on lipoproteins in man. Ann Rev Nutr 1995; 15:473-493.
2. Evans ME, Brown JM, McIntosh MK. Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J Nutr Biochem 2002; 13:508-516.
3. Mensink RP, Zock PL, Kester A, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol ratio and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77:1146-1155.
4. Ascherio A, Katan MB, Zock PL, et al. Trans fatty acids and coronary heart disease. N Engl J Med 1999; 340:1994-1998.
5. Mauger J-F, Lichtenstein AH, Ausman LM, et al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 2003; 78:370-375. This study reported that consumption of trans fatty acids caused a small decrease in LDL particle size. Small, dense LDL is positively related to the risk for cardiovascular disease.
6. Kraus RM. Dietary and genetic effects on low-density lipoprotein heterogeneity. Annu Rev Nutr 2001; 21:283-295.
7. Cuchel M, Schwab US, Jones PJH, et al. Impact of hydrogenated fat consumption on endogenous cholesterol synthesis and susceptibility of low-density lipoprotein to oxidation in moderately hypercholesterolemic individuals. Metabolism 1996; 45:241-247.
8. Mozaffarian D, Pischon T, Hankinson SE, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004; 79:606-612. In this cross-sectional study, a positive relation was found between the consumption of trans fatty acids with soluble tumor necrosis factor α receptors 1 and 2, two markers of systemic inflammation.
9. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 1996; 146:231-240.
10. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004; 79:969-973. This dietary intervention study suggests that both trans fatty acids and stearic acid increase concentrations of plasma markers of inflammation.
11. Wolff RL, Precht D, Molkentin J. Occurrence and distribution profiles of trans-18:1 acids in edible fats of natural origin. In: Sébédio JL, Christie WW, editors. Trans fatty acids in human nutrition. Dundee: The Oily Press; 1998. pp.1-33.
12. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993; 341:581-585.
13. Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the alpha-tocopherol, beta-carotene cancer prevention study. Am J Epidemiol 1997; 145:876-887.
14. Oomen CM, Ockè MC, Feskens EJM, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen elderly study: a prospective population-based study. Lancet 2001; 357:746-751.
15. Weggemans RM, Rudrum M, Trautwein EA. Intake of ruminant versus industrial trans fatty acids and risk of coronary heart disease: what is the evidence?. Eur J Lipid Sci Technol 2004; 106:390-397.
16. Clifton PM, Keogh JB, Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 2004; 134:874-879.
17. Baylin A, Kabagambe EK, Ascherio A, et al. High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J Nutr 2003; 133:1186-1191.
18. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr 2002; 22:505-531.
19. Larsen TM, Toubro S, Astrup A. Efficacy and safety of dietary supplements containing CLA for the treatment of obesity: evidence from animal and human studies. J Lipid Res 2003; 44:2234-2241. A good overview on the isomer-specific effects of CLA on body composition and lipid metabolism. Safety aspects are also discussed.
20. Terpstra AHM. Effect of conjugated linoleic acid on body composition and plasma lipids in human: an overview of the literature. Am J Clin Nutr 2004; 79:352-361. A comprehensive review on the effects in humans of CLA on body composition, serum lipids and glucose metabolism.
21. Malpuech-Brugère C, Verboeket-van de Venne WPHG, Mensink RP, et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 2004; 12:591-598. A human study showing that supplementation of c9,t11-CLA or t10,c12-CLA for 18 weeks has no statistically significant effect on body composition in overweight, middle-aged men and women.
22. Gaullier J-M, Halse J, Høye K, Kristiansen K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004; 79:1118-1125. This paper shows that long-term supplementation of a mixture of CLA isomers may be needed before any effects on body fat mass are evident. However, fasting concentrations of plasma lipids or glucose were not improved.
23. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56:320-328.
24. Diabetes Prevention Program Research Group. Reduction in body the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-404.
25. Tricon S, Burdge GC, Kew S, et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 2004; 80:614-620. In this study, no consistent effects of the two isomers on body composition were observed. Compared with the c9,t11-CLA isomer, t10,c12-CLA increased plasma triacylglycerol, total and LDL cholesterol, and glucose concentrations.
26. Risérus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002; 25:1516-1521.
27. Risérus U, Vessby B, Ärnlöv J, Basu S. Effects of cis9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 2004; 80:279-283. This study in obese men suggests that - like t10,c12-CLA - c9,t12-CLA increased insulin resistance and lipid peroxidation.
28. Belury MA, Mahon A, Banni S. The conjugated linoleic acid (CLA) isomer t10,c12-CLA is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J Nutr 2003; 133:257S-260S.
29. Kamphuis MMJW, Lejeune MPGM, Saris WHM, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord 2003; 27:840-847.
30. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.